TABLE 2.
Clinical data of patients in the IMN and control groups
| IMN group | Control group | p value | |
|---|---|---|---|
| N | 55 | 58 | – |
| Age a | 50.2 ± 12.1 | 47.4 ± 13.1 | 0.244 |
| Gender (M: F) b | 27: 28 | 29: 29 | 0.923 |
| Alb (g/L) a | 24.8 ± 5.2 | 46.2 ± 2.5 | <0.0001 |
| Urea (mmol/L) a | 6.9 ± 2.9 | 4.9 ± 1.1 | <0.0001 |
| Crea (μmol/l) a | 68.7 ± 15.9 | 68.9 ± 12.6 | 0.957 |
| Cysc (mg/L) a | 1.28 ± 0.38 | 0.80 ± 0.11 | <0.0001 |
| eGFR (ml/min/1.73 m2) a | 77.36 ± 19.92 | 104.09 ± 14.21 | <0.0001 |
| 24 h‐UP (mg/24 h) | 5.0 ± 3.3 | – | – |
“N” represents the number of patients in each group. Age, Alb, Urea, Crea, Cysc, eGFR, and 24 h‐UP followed a normal distribution and were expressed as mean ± standard deviation.
p < 0.05 was considered statistically significant.
a
Comparisons made by t test.
b
Comparisons made by χ 2 test.